Business
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
GAITHERSBURG, Md., January 07, 2026--GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal anomalies are identified.
About this update from Genedx Holdings Corp.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":417,"url":"https://media.zenfs.com/en/business-wire.com/e1263d9604fc4df4d35c54ab4b175062"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rSGEfvPhcE.FkYIauYoWvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzNDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e1263d9604fc4df4d35c54ab4b175062","width":960,"height":334},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/TzTP7BCVpoRN0JBuIgv5Qw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/e1263d9604fc4df4d35c54ab4b175062","width":1200,"height":417}},"lazy":false},{"type":"text","content":"New whole genome sequencing test delivers fast, comprehensive insights when fetal anomalies are identified, reinforcing GeneDx’s commitment to enabling precise, fast, and actionable rare disease diagnosis at the earliest moment possible","length":236,"tagName":"p","attribs":{}},{"type":"text","content":"GAITHERSBURG, Md., January 07, 2026--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced GenomeDx Prenatal™, whole genome sequencing (WGS) designed to deliver clear, reliable answers during one of the most critical moments in pregnancy care. The phenotype-informed, trio-based test is intended for pregnancies with fetal anomalies identified via ultrasound, enabling clinicians and expecting families to access actionable genomic insights with a rapid turnaround time. In contrast to carrier or noninvasive prenatal screening that identifies pregnancies at risk of having a genetic disorder, prenatal diagnostic testing can determine whether a pregnancy is affected by a genetic disorder.","length":765,"tagName":"p"},{"type":"text","content":"With more than a decade of experience in prenatal diagnostics – including over 10 years of prenatal exome testing and more than 4,000 prenatal exomes performed – GeneDx brings its proven genomic expertise and the power of GeneDx Infinity ™, the largest rare disease dataset, into prenatal care. GenomeDx Prenatal builds on this foundation, combining comprehensive variant detection with deep clinical interpretation to help inform diagnosis, guide prenatal and postnatal care, and support care decisi...